Sisa Journal reported that Apple is set to release the “iPhone 17 Air” in September, which will be the thinnest iPhone ever at 6.25mm, 20-25% thinner than the iPhone 16 models. The device will not have a “Plus” version and is expected to start at $899 in the U.S. Additionally, Apple is rumored to be working on foldable devices and a smart home device to compete with Amazon and Google.
Full Article
3 Magnificent Stocks That Could Double or More by 2030
In a turbulent stock market, three Motley Fool contributors recommend investing in CRISPR Therapeutics, Summit Therapeutics, and Viking Therapeutics, which they believe could see significant gains by 2030. CRISPR Therapeutics, despite recent struggles, has a promising gene-editing therapy, Casgevy, and a robust pipeline. Summit Therapeutics is poised to challenge established drugs with its ivonescimab, while Viking Therapeutics offers potential through its GLP-1 drug, VK2735, with ongoing clinical trials targeting obesity and metabolic disorders. Full Article
Read more